Shattuck Labs, Inc. · NASDAQ:STTK

Orbimed Advisors LLC reported a 9.99% stake in Shattuck Labs, Inc. (Schedule 13D/A)

Event Jun 11, 2026 · Filed Jun 15, 2026

Orbimed Advisors LLC reported a 9.99% stake in Shattuck Labs, Inc., 9,021,127 shares, with active intent on Jun 11, 2026. Filed Jun 15, 2026 (Schedule 13D/A).

Stake
9.99%
Shares
9,021,127
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC9.99%9,021,127
OrbiMed Capital GP IX LLC8.33%7,517,606
OrbiMed Genesis GP LLC1.67%1,503,521

Source

View original at SEC

Related